19th April 2016
Early trials carried out on mice are suggesting that natural protein injections could slow the progress of Alzheimer's dementia.
Similarly, the injections may also be able to lessen the severity of the symptoms in patients, reports the BBC.
The treatment, known as Interleukin 33 (IL 33), has so far seemed to improve memory and help clear and prevent brain deposits in mice, that are akin to those seen in human sufferers of this degenerative disease.
As a response to the success, there will be human studies beginning with the protein injections soon, but those experts involved say that it will take a long time before we know if the treatment will help patients en masse.
IL 33 is actually made by the body naturally, as part of its immune defence against general infection and disease. The protein is particularly adept at defending against infections in the brain and spinal cord.
So far, the research has shown that adults with Alzheimer's have less IL 33 in their brains than healthy people.
Professor Eddy Liew, lead doctor of the study at University of Glasgow, said: "Exciting as it is, there is some distance between laboratory findings and clinical applications. There have been enough false 'breakthroughs' in the medical field to caution us not to hold our breath until rigorous clinical trials have been done."
Posted by Jeanette Royston
Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.